Cargando…

Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients

Background: Severe pneumonia and acute respiratory distress syndrome (ARDS) due to COVID-19 is a challenge for nowadays medical practice. Although there is no clarity in the principal mechanism of lung damage and ARDS development, it has been suggested that one of the main reasons of this pathology...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cala-García, Juan David, Sierra-Bretón, Juan David, Cavelier-Baiz, Jorge Eduardo, Faccini-Martínez, Álvaro A, Pérez-Díaz, Carlos Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363061/ https://www.ncbi.nlm.nih.gov/pubmed/32664810 http://dx.doi.org/10.2217/imt-2020-0154

Ejemplares similares

Association of Tocilizumab and Invasive Aspergillosis in Critically Ill Patients with Severe COVID-19 Pneumonia and Acute Respiratory Distress Syndrome
por: Wu, Kuo-Lun, et al.
Publicado: (2022)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Tocilizumab in critically ill COVID-19 patients: An observational study
por: Mushtaq, Muhammad Z., et al.
Publicado: (2022)

Successful treatment of a critical COVID-19 patient with tocilizumab
por: Tsao, Shih-Ming, et al.
Publicado: (2021)

Goal-Oriented Respiratory Management for Critically Ill Patients with Acute Respiratory Distress Syndrome
por: Barbas, Carmen Sílvia Valente, et al.
Publicado: (2012)

Prediction Model for Critically Ill Patients with Acute Respiratory Distress Syndrome
por: Zhang, Zhongheng, et al.
Publicado: (2015)

Precision Medicine in Critical Illness: Sepsis and Acute Respiratory Distress Syndrome
por: Rogers, Angela J., et al.
Publicado: (2019)

Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2
por: Petrak, Russell M., et al.
Publicado: (2021)

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients
por: Bhandari, Sudhir, et al.
Publicado: (2021)

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
por: Petrak, Russell M., et al.
Publicado: (2021)

Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis
por: Auriemma, Catherine L., et al.
Publicado: (2020)

Clinical predictors of renal non-recovery in acute respiratory distress syndrome
por: Panitchote, Anupol, et al.
Publicado: (2019)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab()
por: Figuero-Pérez, Luis, et al.
Publicado: (2021)

Hyperproteic hypocaloric enteral nutrition in the critically ill patient: A randomized controlled clinical trial
por: Rugeles, Saúl-Javier, et al.
Publicado: (2013)

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
por: Dufranc, Etienne, et al.
Publicado: (2020)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
por: Camou, Fabrice, et al.
Publicado: (2022)

Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19
por: Szabo, Robert, et al.
Publicado: (2023)

The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome
por: Battaglini, Denise, et al.
Publicado: (2021)

Lung Ultrasound in COVID-19 Critically Ill Patients with Acute Respiratory Distress Syndrome
por: Storti, Enrico, et al.
Publicado: (2020)

Correction to: Clinical predictors of renal non-recovery in acute respiratory distress syndrome
por: Panitchote, Anupol, et al.
Publicado: (2019)

Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics
por: Elhazmi, Alyaa, et al.
Publicado: (2023)

Development and early diagnosis of critical illness myopathy in COVID‐19 associated acute respiratory distress syndrome
por: Rodriguez, Belén, et al.
Publicado: (2022)

Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review
por: Robba, Chiara, et al.
Publicado: (2021)

Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study
por: Huang, Edmund, et al.
Publicado: (2021)

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis
por: Rajendram, Prabalini, et al.
Publicado: (2021)

Utility of the Modified Nutritional Risk in the Critically ill Score as an Outcome Predictor in All-Cause Acute Respiratory Distress Syndrome and Acute Febrile Illness-Induced Acute Respiratory Distress Syndrome
por: Todur, Pratibha, et al.
Publicado: (2022)

Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale
por: Nasir, Nosheen, et al.
Publicado: (2020)

Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome
por: Kempf, Tibor, et al.
Publicado: (2013)

Predictors of survival in critically ill patients with acute respiratory distress syndrome (ARDS): an observational study
por: Balzer, Felix, et al.
Publicado: (2016)

Microcirculatory Alterations in Critically Ill Patients with COVID-19-Associated Acute Respiratory Distress Syndrome
por: Di Dedda, Umberto, et al.
Publicado: (2022)

Ventilator avoidance among critically ill COVID-19 patients with acute respiratory distress syndrome
por: Fletcher, Jeffrey J, et al.
Publicado: (2022)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study
por: Hafez, Wael, et al.
Publicado: (2022)

Sleep after critical illness: Study of survivors of acute respiratory distress syndrome and systematic review of literature
por: Dhooria, Sahajal, et al.
Publicado: (2016)

Long-term outcome after the acute respiratory distress syndrome: different from general critical illness?
por: Bein, Thomas, et al.
Publicado: (2018)

Obesity and survival in critically ill patients with acute respiratory distress syndrome: a paradox within the paradox
por: Ball, Lorenzo, et al.
Publicado: (2017)

Linear Association Between Hypoalbuminemia and Increased Risk of Acute Respiratory Distress Syndrome in Critically Ill Adults
por: McNeil, J. Brennan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hmbucvncesq412gv1aus24r0d7